Tower Research Capital (TRC)’s Bone Biologics BBLG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $806 | Sell |
200
-104
| -34% | -$419 | ﹤0.01% | 4936 |
|
|
2025
Q1 | $1.46K | Sell |
304
-261
| -46% | -$1.25K | ﹤0.01% | 4705 |
|
|
2024
Q4 | $3.18K | Buy |
565
+267
| +90% | +$1.51K | ﹤0.01% | 4694 |
|
|
2024
Q3 | $3.8K | Sell |
298
-667
| -69% | -$8.51K | ﹤0.01% | 4771 |
|
|
2024
Q2 | $7.06K | Buy |
965
+257
| +36% | +$1.88K | ﹤0.01% | 4503 |
|
|
2024
Q1 | $9.05K | Buy |
708
+504
| +247% | +$6.44K | ﹤0.01% | 3909 |
|
|
2023
Q4 | $5.54K | Buy |
204
+65
| +47% | +$1.76K | ﹤0.01% | 4828 |
|
|
2023
Q3 | $4.75K | Buy |
139
+13
| +10% | +$444 | ﹤0.01% | 4818 |
|
|
2023
Q2 | $8.64K | Buy |
126
+120
| +2,000% | +$8.23K | ﹤0.01% | 4377 |
|
|
2023
Q1 | $2K | Hold |
6
| – | – | ﹤0.01% | 5309 |
|
|
2022
Q4 | $2K | Buy |
6
+1
| +20% | +$333 | ﹤0.01% | 5327 |
|
|
2022
Q3 | $8K | Buy |
5
+1
| +25% | +$1.6K | ﹤0.01% | 4761 |
|
|
2022
Q2 | $9K | Buy |
+4
| New | +$9K | ﹤0.01% | 4536 |
|